QA: Global Blood Therapeutics Inc in us_pharma/2015

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001629137_2016_Global_Blood_Therapeutics_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001629137, Global Blood Therapeutics Inc

  xvar xval
0 AssetsCurrent 150,820,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 2,114,000
3 remainder_Assets 140,000
4 LiabilitiesCurrent 10,723,000
5 LiabilitiesNoncurrent 1,556,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 9,671,000
9 ResearchAndDevelopmentExpense 36,657,000
10 remainder_Expenses 65,000
11 remainder_Revenues 0
12 remainder_NetIncome 33,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 153,074,000
1 Liabilities 12,279,000
2 Expenses 46,393,000
3 Revenues 0
4 StockholdersEquity 140,795,000
5 NetIncome -46,360,000
6 ComprehensiveNetIncome -46,360,000
7 BaseVar 105,889,500
8 EconomicCapitalRatiobeforeLimitedLiability 3.15
9 EconomicCapitalRatio 3.79

Edgar->Model Mapping

Feature Distribution